| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.008 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.009 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |